Companies in #Pulmonary Hypertension
Found 2 companies operating in this sector.
Kardigan
PrivateKardigan is a clinical-stage cardiovascular biotechnology company founded by Tassos Gianakakos, the former CEO of MyoKardia (acquired by Bristol-Myers Squibb for $13B), with a portfolio of in-licensed cardiovascular drug candidates targeting cardiomyopathies and related heart conditions.
United Therapeutics is a biotechnology company focused on developing therapies for pulmonary arterial hypertension and other rare diseases.